Get the Stockscreener App
3.475
4.51%
-0.1643
After Hours:
3.36
-0.115
-3.31%
Qualigen Therapeutics Inc Stock (QLGN) Forecast
The Qualigen Therapeutics Inc (QLGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $22.87, representing a +558.21% increase from the current price of $3.475. The highest analyst price target is $22.52, and the lowest is $23.22.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month QLGN Price Target
Average 24.67
(+609.88% Upside)
Is Qualigen Therapeutics Inc (QLGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.85 | Neutral |
| STOCH(9,6) | 66.78 | Neutral |
| STOCHRSI(14) | 51.96 | Neutral |
| MACD(12,26) | 0.0804 | Buy |
| ADX(14) | 33.47 | Buy |
| William %R | -59.67 | Neutral |
| CCI(14) | 40.19 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.4234
Buy
|
3.4864
Sell
|
| MA20 |
3.3687
Buy
|
3.4004
Buy
|
| MA50 |
3.3056
Buy
|
3.4422
Buy
|
| MA100 |
3.6561
Sell
|
4.1398
Sell
|
| MA200 |
6.181
Sell
|
7.0103
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, QLGN could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 5 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on QLGN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 52.85 indicates that QLGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 66.78 indicates that QLGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 51.96 indicates that QLGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.47 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 40.19 indicates that QLGN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term QLGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Qualigen Therapeutics Inc financial reports and earnings history, Qualigen Therapeutics Inc (QLGN) stock could reach $63.13 by 2030, $70.35 by 2040 and $326.46 by 2050. See the projected annual prices until 2050 of the Qualigen Therapeutics Inc stock below:
- Qualigen Therapeutics Inc (QLGN) is expected to reach an average price of $75.49 in 2035, with a high prediction of $77.05 and a low estimate of $75.58. This indicates an $2,072% rise from the last recorded price of $3.475.
- Qualigen Therapeutics Inc (QLGN) stock is projected to chart a bullish course in 2040, with an average price target of $67.59, representing an $1,845% surge from its current level. The forecast ranges from a conservative $67.59 to a sky-high $70.35.
- Our analysts predict Qualigen Therapeutics Inc (QLGN) to jump 955.98% by 2045, soaring from $36.77 to an average price of $36.70, potentially reaching $40.32. While $36.77 is the low estimate, the potential upside is significant.
- Qualigen Therapeutics Inc (QLGN) stock is expected to climb by 2050, reaching an average of $321.96, a $9,165% jump from its current level. However, a wide range of estimates exists, with high and low targets of $326.46 and $324.46, respectively, highlighting the market's uncertainty.
Qualigen Therapeutics Inc Stock (QLGN) Year by Year Forecast
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2025
Qualigen Therapeutics Inc Stock (QLGN) is expected to reach an average price of $21.45 in 2025, with a high prediction of $26.17 and a low estimate of $16.73. This indicates an +517.19% rise from the last recorded price of $3.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $24.07 | $23.22 | $22.52 | +592.77% |
| June, 2025 | $28.88 | $23.29 | $23.43 | +731.15% |
| July, 2025 | $24.24 | $25.39 | $25.93 | +597.66% |
| August, 2025 | $26.15 | $25.50 | $25.35 | +652.60% |
| September, 2025 | $25.96 | $26.06 | $25.96 | +647.10% |
| October, 2025 | $24.72 | $23.17 | $26.17 | +611.45% |
| November, 2025 | $24.53 | $24.73 | $24.23 | +605.95% |
| December, 2025 | $25.30 | $24.83 | $25.21 | +627.98% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2026
The predicted value for Qualigen Therapeutics Inc (QLGN) in 2026 is set at an average of $22.83. Estimates vary from a peak of $26.00 to a trough of $19.66, indicating an +557.00% surge from the present price of $3.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $26.60 | $25.85 | $26.00 | +665.59% |
| February, 2026 | $25.98 | $26.54 | $25.96 | +647.63% |
| March, 2026 | $25.07 | $24.92 | $24.81 | +621.41% |
| April, 2026 | $24.35 | $24.62 | $24.13 | +600.67% |
| May, 2026 | $22.97 | $23.29 | $23.93 | +560.87% |
| June, 2026 | $22.10 | $22.39 | $22.08 | +536.03% |
| July, 2026 | $22.37 | $22.39 | $22.00 | +543.81% |
| August, 2026 | $21.67 | $21.82 | $21.58 | +523.58% |
| September, 2026 | $21.48 | $21.38 | $21.24 | +518.26% |
| October, 2026 | $20.88 | $20.96 | $20.98 | +500.88% |
| November, 2026 | $20.25 | $20.53 | $20.59 | +482.75% |
| December, 2026 | $19.63 | $19.66 | $19.73 | +464.88% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Qualigen Therapeutics Inc (QLGN) is $13.44, with a high forecast of $19.31 and a low forecast of $7.5707. This indicates an +286.80% increase from the last price of $3.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.69 | $18.88 | $19.31 | +437.80% |
| February, 2027 | $17.84 | $17.93 | $18.27 | +413.31% |
| March, 2027 | $16.74 | $16.78 | $17.40 | +381.82% |
| April, 2027 | $15.94 | $15.97 | $16.42 | +358.57% |
| May, 2027 | $14.94 | $14.97 | $15.66 | +329.84% |
| June, 2027 | $13.74 | $13.75 | $14.67 | +295.31% |
| July, 2027 | $12.73 | $12.73 | $13.46 | +266.24% |
| August, 2027 | $11.58 | $11.79 | $12.45 | +233.23% |
| September, 2027 | $10.42 | $10.42 | $11.22 | +199.78% |
| October, 2027 | $9.4462 | $9.4662 | $10.10 | +171.83% |
| November, 2027 | $8.4551 | $8.4951 | $9.1384 | +143.31% |
| December, 2027 | $7.4486 | $7.5707 | $8.1174 | +114.35% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2028
In 2028, Qualigen Therapeutics Inc (QLGN) is projected to reach an average price of $32.62, with a high projection of $64.99 and a low estimate of $0.2548. This indicates an +838.78% rise from the last price of $3.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.5577 | $6.5577 | $7.1796 | +88.71% |
| February, 2028 | $5.6663 | $5.6743 | $6.2049 | +63.06% |
| March, 2028 | $4.5037 | $4.5135 | $5.3896 | +29.60% |
| April, 2028 | $3.5229 | $3.564 | $4.2377 | +1.38% |
| May, 2028 | $2.3707 | $2.3827 | $3.1927 | -31.78% |
| June, 2028 | $1.3894 | $1.4246 | $2.0979 | -60.02% |
| July, 2028 | $0.4938 | $0.5031 | $1.1369 | -85.79% |
| August, 2028 | $59.81 | $0.2548 | $58.01 | +1,621% |
| September, 2028 | $59.93 | $61.02 | $62.33 | +1,625% |
| October, 2028 | $54.45 | $57.55 | $56.34 | +1,467% |
| November, 2028 | $68.27 | $58.45 | $63.97 | +1,865% |
| December, 2028 | $65.09 | $67.09 | $64.99 | +1,773% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2029
The 2029 price forecast for Qualigen Therapeutics Inc Stock (QLGN) is $63.08 on average, with a high prediction of $69.82 and a low estimate of $56.34. This represents an +1,715% increase from the previous price of $3.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $65.51 | $66.40 | $66.21 | +1,785% |
| February, 2029 | $56.33 | $64.23 | $61.72 | +1,521% |
| March, 2029 | $65.45 | $56.34 | $58.75 | +1,783% |
| April, 2029 | $65.27 | $63.36 | $63.87 | +1,778% |
| May, 2029 | $68.29 | $65.64 | $69.51 | +1,865% |
| June, 2029 | $68.71 | $70.31 | $69.82 | +1,877% |
| July, 2029 | $64.22 | $66.32 | $66.51 | +1,748% |
| August, 2029 | $65.75 | $65.64 | $64.44 | +1,792% |
| September, 2029 | $69.57 | $64.22 | $64.85 | +1,902% |
| October, 2029 | $63.69 | $65.08 | $66.37 | +1,733% |
| November, 2029 | $64.61 | $64.50 | $63.81 | +1,759% |
| December, 2029 | $63.42 | $63.52 | $63.81 | +1,725% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2030
Qualigen Therapeutics Inc Stock (QLGN) is expected to reach an average price of $54.54 in 2030, with a high forecast of $63.13 and a low forecast of $45.96. This signifies an +1,470% surge from the last price of $3.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $60.95 | $59.64 | $63.13 | +1,654% |
| February, 2030 | $59.76 | $59.96 | $59.95 | +1,620% |
| March, 2030 | $60.38 | $59.56 | $58.98 | +1,638% |
| April, 2030 | $59.47 | $59.47 | $59.21 | +1,611% |
| May, 2030 | $57.99 | $58.62 | $59.00 | +1,569% |
| June, 2030 | $56.09 | $56.19 | $56.58 | +1,514% |
| July, 2030 | $54.13 | $54.76 | $54.16 | +1,458% |
| August, 2030 | $51.76 | $52.08 | $53.47 | +1,389% |
| September, 2030 | $49.90 | $50.19 | $50.62 | +1,336% |
| October, 2030 | $48.93 | $49.02 | $49.50 | +1,308% |
| November, 2030 | $47.24 | $47.54 | $47.83 | +1,259% |
| December, 2030 | $45.96 | $45.96 | $46.56 | +1,222% |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):